Facebook
Twitter
LinkedIn
ForwardPulse- Vasoplegia and the Role of Angiotensin II
New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.
Vasoplegia is a recognized hemodynamic challenge seen in different settings such as in post-operative cardiotomy and sepsis. Treatment typically involves fluids, norepinephrine, and other vasopressors and non-catecholamine agents; however, there is no standardized approach to treating vasoplegia, including refractory vasoplegia for patients non-responsive to initial therapies. The purpose of this presentation is to assess the potential role of angiotensin II, administration and dosing regimens, risk vs. benefit, controversies, limitations, and cost/formulary considerations.
Target Audience
Pharmacist
Learning Objectives
1. Define vasoplegia in the setting of sepsis and post-cardiotomy shock
2. Discuss the current vasoplegia treatment management approach
3. Identify the appropriateness and place in therapy of Angiotensin II
Additional Information
| Attachment | Size |
|---|---|
 Audience Disclosure slide_20.pptx | 460.21 KB |
 Abstract_KimLakic.pdf | 148.6 KB |
New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.
Vasoplegia is a recognized hemodynamic challenge seen in different settings such as in post-operative cardiotomy and sepsis. Treatment typically involves fluids, norepinephrine, and other vasopressors and non-catecholamine agents; however, there is no standardized approach to treating vasoplegia, including refractory vasoplegia for patients non-responsive to initial therapies. The purpose of this presentation is to assess the potential role of angiotensin II, administration and dosing regimens, risk vs. benefit, controversies, limitations, and cost/formulary considerations.
Jean Kim, PharmD
Jelena Lakic, PharmD
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Pharmacy (CPE)
This knowledge-based activity provides 1.0 contact hours of continuing pharmacy education credit.
Available Credit
- 1.00 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.